- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.11. | 4Front Ventures GAAP EPS of -$0.01, revenue of $17.1M | 2 | Seeking Alpha | ||
| 14.11. | 4Front Ventures Corp.: 4Front Ventures Reports Third Quarter 2024 Results | 154 | PR Newswire | Q3 2024 Revenue of $ 17.1 Million
Q3 Adjusted EBITDA1 of $1.0 Million
Matteson Facility Nears Full Operational Capacity in Illinois, Positioning to Meet Growing... ► Artikel lesen | |
| 14.11. | 4Front Ventures Corp. - 8-K, Current Report | - | SEC Filings | ||
| 14.11. | 4Front Ventures Corp. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 07.11. | 4Front Ventures Corp: 4Front Ventures to release Q3 2024 results Nov. 14 | 1 | Stockwatch | ||
| 07.11. | 4Front Ventures to Report Third Quarter 2024 Financial Results on November 14, 2024 | 3 | CNW | ||
| 4FRONT VENTURES Aktie jetzt für 0€ handeln | |||||
| 07.11. | 4Front Ventures Corp. - 8-K, Current Report | - | SEC Filings | ||
| 04.11. | 4Front Ventures Corp: 4Front to hold Matteson facility ribbon-cutting Nov. 6 | 1 | Stockwatch | ||
| 04.11. | 4Front Ventures Corp. Announces Official Ribbon Cutting of Its 250,000 Sq. Ft. Cultivation and Production Facility in Illinois, Now Operational and Serving Mission Dispensaries and the State of Illinois | 1 | CNW | ||
| 30.10. | Cannabis operator 4Front names interim CFO as Peter Kampian transitions out of role | 1 | Seeking Alpha | ||
| 29.10. | 4Front Ventures Corp: 4Front CFO Kampian's contract ends | 1 | Stockwatch | ||
| 29.10. | 4Front Welcomes New Leadership as CFO Peter Kampian Transitions Out of Role | 1 | CNW | ||
| 29.10. | 4Front Ventures Corp. - 8-K, Current Report | 2 | SEC Filings | ||
| 10.10. | 4Front Advisory to Attend BMAC's CHARGED! Battery Conference | 289 | Newsfile | Calgary, Alberta--(Newsfile Corp. - October 10, 2024) - 4Front Advisory, a capital markets firm offering services in corporate finance and capital markets strategy, and investor communication, is pleased... ► Artikel lesen | |
| 26.09. | Marijuana MSO 4Front Ventures amends credit facility, seeks to refine fiscal plan | 2 | Marijuana Business Daily | ||
| 26.09. | 4Front Ventures Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 25.09. | 4Front Ventures Retains Canaccord Genuity to Optimize Capital Structure and Announces Amendment of Credit Facility and Issuance of Restricted Stock Units | 2 | CNW | ||
| 25.09. | 4Front Ventures Corp: 4Front hires Canaccord to consolidate capital structure | 1 | Stockwatch | ||
| 18.09. | 4D Molecular Therapeutics, Inc.: 4DMT Highlights Robust and Durable Clinical Activity for 4D-150 and Design of 4FRONT Phase 3 Program at 4D-150 Wet AMD Development Day | 134 | GlobeNewswire (Europe) | 4D-150 demonstrated robust and durable clinical activity across all wet age-related macular degeneration (wet AMD) patient populations based on longest available follow-up data In broad population... ► Artikel lesen | |
| 15.08. | Multi-State Marijuana Operator 4Front Posts 31% YoY Lower Q2 Revenue, Sees Net Loss Reduction, Remains Focused On Illinois | 2 | Benzinga.com |
Seite:
1 2 3 Weiter >>
42 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 4,100 | +0,49 % | Better Marijuana Stock: Aurora Cannabis or Tilray Brands? | ||
| CANOPY GROWTH | 2,715 | +0,56 % | Canopy Growth: So hoch ist das Insolvenzrisiko | Bei den Papieren von Canopy Growth gibt es nach wie vor kein Licht am Ende des Tunnels. Seit Ende April sind sie um rund 80 Prozent gefallen und steuern auf ein neues Allzeittief zu. Da das Rescheduling... ► Artikel lesen | |
| ASTRAZENECA | 124,55 | +0,04 % | DEUTSCHE BANK RESEARCH stuft ASTRAZENECA auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Astrazeneca mit einem Kursziel von 10500 Pence auf "Hold" belassen. Dies schrieb Analyst Emmanuel Papadakis in seinem am... ► Artikel lesen | |
| TILRAY BRANDS | 1,219 | +2,05 % | Ausverkauf und dann Comeback?: Darum sind Tilray, Canopy & Co. potenzielle Highflyer in 2025. Und darum nicht | © Foto: adobe.stock.comDas Jahresende bringt für den Cannabis-Sektor noch einmal Turbulenzen mit sich. Das Jahr endet, wie es verlief; könnte man salopp formulieren. Zudem dürfte Tilray, Canopy & Co.... ► Artikel lesen | |
| INNOCAN PHARMA | 0,121 | 0,00 % | Innocan Pharma Corporation: Innocan Pharma Announces Private Placement of Units | HERZLIYA, Israel and CALGARY, AB, Dec. 19, 2024 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it... ► Artikel lesen | |
| TAAT GLOBAL ALTERNATIVES | 0,100 | -16,67 % | XFRA 2TP0: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| CRONOS GROUP | 1,880 | +0,27 % | Why Cronos Group (CRON) Is Among the Best Cannabis Stocks To Invest In? | ||
| SYNBIOTIC | 4,000 | -1,23 % | EQS-News: SYNBIOTIC SE: Richtungsweisende Dekontamination: SYNBIOTIC und GOC NEXUS setzen Goldstandard für Cannabis | EQS-News: SYNBIOTIC SE
/ Schlagwort(e): Beteiligung/Unternehmensbeteiligung
Richtungsweisende Dekontamination: SYNBIOTIC und GOC NEXUS setzen Goldstandard für Cannabis
18.12.2024... ► Artikel lesen | |
| TRANSCANNA | 0,017 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM XETRA - 02.07.2024 | The following instruments on XETRA do have their last trading day on 02.07.2024Die folgenden Instrumente in XETRA haben ihren letzten Handelstag am 02.07.2024ISIN NameGB00BMGRFP88 CITIUS RESOURCES LS-... ► Artikel lesen | |
| DIGICANN VENTURES | 0,004 | 0,00 % | CSE Bulletin: Halted for Fundamental Change - Digicann Ventures Inc. (DCNN) | le 30 septembre/September 2024
Trading in the shares of Digicann Ventures Inc. will remain halted pending receipt and review of acceptable documentation regarding the Fundamental Change pursuant... ► Artikel lesen | |
| WPD PHARMACEUTICALS | 0,003 | 0,00 % | CSE Bulletin: Reinstatement - WPD Pharmaceuticals Inc. (WBIO) | Toronto, Ontario--(Newsfile Corp. - le 20 décembre/December 2024) - Effective immediately, WPD Pharmaceuticals Inc. will be reinstated for trading. The Company has rectified the situation... ► Artikel lesen | |
| ORGANIGRAM | 1,460 | -2,14 % | Organigram Reports Fourth Quarter and Fiscal 2024 Results | TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer ("LP") of cannabis, announced its results for the fourth... ► Artikel lesen | |
| CRESCO LABS | 0,850 | -0,23 % | Cresco Labs Demonstrates Success of Cash Flow Focused Strategy with Third Quarter 2024 Financial Results | Record quarterly operating cash flow of $49 million and year to date operating cashflow of $103 million, an increase of 66% from the prior year period
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF)... ► Artikel lesen | |
| GREEN THUMB INDUSTRIES | 7,500 | -0,86 % | Multi-Bagger entdeckt!: Der europäische Cannabissektor wird in den nächsten Jahren auf 24 Mrd. $ explodieren - diese Aktie profitiert! | ||
| SNDL | 1,721 | -0,52 % | Why SNDL Inc. (SNDL) Is Among the Best Cannabis Stocks To Invest In? |
4FRONT VENTURES CORP gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu 4FRONT VENTURES CORP finden Sie auf Wallstreet Online.
